Get a Clearer Clinical Picture with the SARS-CoV-2 Total Assay
Understand why Total Antibody Testing Matters
|
|
Click through to get a quick understanding of the science and scale behind the COV2T Assay
|
|
- What is the S1RBD antigen?
- What’s the difference between IgG and IgM?
- How can we address recovery on a global scale?
Our SARS-CoV-2 Total (COV2T) Assay* can be used effectively for broad population testing with the accuracy, speed, and large availability that meets the high demand. Broad population testing for antibodies has the potential to help re-open society in a smart way.
|
|
|
*This test has not been FDA cleared or approved. This test has been authorized by FDA under an EUA for use by authorized laboratories. This test has been authorized only for detecting the presence of antibodies against SARS-CoV-2, not for any other viruses or pathogens. This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner. Product availability may vary by country and is subject to regulatory requirements.
|
|
|
|
